ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 286193 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 286193; 2) Community: the network communities that were significantly associated with the response to NSC 286193; 3) Molecule: the relationships between components within communities and NSC 286193; 4) MDR: the compounds that were significantly associated with the NSC 286193.

NSC Compound Enrichment Correlation
NSC 721049 7Z-Plakortide H 0.00628187335688605 0.1352302
NSC 722867 Null 0.00628187335688605 0.1711913
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00628187335688605 0.156938
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.00628187335688605 0.24514714
NSC 736811 Null 0.00628187335688605 0.32328926
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.00628187335688605 0.29296652
NSC 102067 6H-Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 0.00701295499506013 0.24606785
NSC 357114 CS-12350 0.00701295499506023 0.12905955
NSC 365798 Fostamatinib disodium, Tamatinib fosdium 0.00701295499506023 0.27369506
NSC 613012 BENGAMIDE A 0.00701295499506023 0.43582163
Total:96  Current:16    [First] [Prev] [Next] [Last]